Conclusion Diabetes mellitus is actually one of the most popular chronic ailments in nearly whole countries.

Slides:



Advertisements
Similar presentations
Role of Amylin and Glucagon in Postprandial Glycemic Excursions in Pediatric Type 1 Diabetes. Rubina Heptulla MD, Luisa M. Rodriguez MD and Morey W. Haymond.
Advertisements

Beliefs of Australian Diabetes Educators in the Care of People with Diabetes and Intellectual Disability Beliefs of Australian Diabetes Educators in the.
Canadian Diabetes Assocaition Clinical Practice Guidelines Pharmacotherapy in Type 1 Diabetes Chapter 12 Angela McGibbon, Cindy Richardson, Cheri Hernandez,
Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes.
INSULIN STRATEGIES IN TYPE 2 DIABETES. The epidemic of type 2 diabetes and the recognition that achieving specific glycemic goals can substantially reduce.
Insulin therapy.
INSULIN THERAPY IN TYPE 1 DIABETES
Consider this Combo: GLP-1 Receptor Agonists and Basal Insulin Matt Heinsen, PharmD PGY2 Pharmacotherapy Resident Butler University & Community Health.
Journal Club 2009 年 1 月 29 日(木) 8 : 20 ~ 8 : 50 B 棟 8 階カンファレンスルーム 薬剤部 TTSP 石井 英俊.
Tresiba- insulin degludec
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA.
GLP-1 Agonists and DPP-4 Inhibitors How do they work? Part 4.
Introduction Subcutaneous insulin absorption is not reproducible and insulin entry directly into the circulation is not linked to glucose sensing Basal.
Glucose Metabolism Dr Lenon T Gwaunza MBChB, BSc (Hons), MSc (UCL)
Aim: What is diabetes and how is it treated?. 1) What causes Diabetes Mellitus? It is caused by an insulin deficiency (pancreas does not produce insulin)
What's New in Basal Insulin for Diabetes
Representative insulin regimens for the treatment of diabetes
Screening System for Hypertension and Diabetes at Primary Care Level
Achieving Optimal Glycaemic Control: Can Insulin Deliver?
Beliefs of Australian Diabetes Educators in the Care
Dulaglutide Drugbank ID : DB09045.
Mastery of Medicine in Diabetes Management Video Roundtable
Albiglutide Drugbank ID : DB09043.
Representative insulin regimens for the treatment of diabetes
Recommendation In people with clinical cardiovascular disease in whom glycemic targets are not met, a SGLT2 inhibitor with demonstrated cardiovascular.
Representative insulin regimens for the treatment of diabetes
Representative insulin regimens for the treatment of diabetes
Key publication slides
Representative insulin regimens for the treatment of diabetes
Diabetes Medications in the Top 200
Utilizing New Technologies and Insulins for a Tighter Grip on PPG
Diabetes and Bone: the model of GIO
Jean L. Chan, MD, Martin J. Abrahamson, MD  Mayo Clinic Proceedings 
Nat. Rev. Nephrol. doi: /nrneph
Glucose homeostasis: roles of insulin and glucagon. 1A.
Nat. Rev. Endocrinol. doi: /nrendo
Insulin and glucagon secretion: nondiabetic and diabetic subjects.
Figure 2 Pharmacokinetic action profiles of rapid-acting insulins
Gerry H. Tan, M.D., Roger L. Nelson, M.D.  Mayo Clinic Proceedings 
Glucose homeostasis: roles of insulin, glucagon, amylin, and GLP-1.
1.
Volume 150, Issue 2, Pages (February 2016)
Younger Patients With Type 1 Diabetes: Can We Optimize Their Insulin Therapy?
Nat. Rev. Endocrinol. doi: /nrendo
Update on cystic fibrosis-related diabetes
Figure 3 Pharmacodynamic action profiles of long-acting insulins
Pathophysiology Of Diabetes Mellitus
What is type 2 diabetes? Medicine
Disorders Associated with Insulin and Glucagon
Carbohydrate absorption inhibitors α-glucosidose inhibitors
INSULINS Dr.R.Sajjad december INSULINS Dr.R.Sajjad december 2018.
VAN GLP-1R kd disturbed postmeal glycemia and insulinemia but did not impair tolerance of an oral glucose bolus. VAN GLP-1R kd disturbed postmeal glycemia.
1018-NT-β-cell clusters protect mice from STZ-induced diabetes.
Mean (±SE) plasma glucose concentrations before, during, and after infusions of octreotide (with growth hormone) with saline (•), with insulin replacement.
Plasma glucose, GIR, rates of EGP and glucose utilization, and plasma concentrations of free fatty acids (FFAs) and β-hydroxy-butyrate after a subcutaneous.
Type 2 Diabetes Story and Treatment For a long time, dietary fat has been recognized a potentially essential modifiable risk agent for diabetes.
Precaution Adoption Process Model (PAPM) Kind 1 diabetes is actually an organ-particular autoimmune ailment.
Insulin analogues: Management and Posology The initial insulin analogues utilized in insulin treatment were the fast-acting insulin analogues.
Multilevel Intervention Most scientific proof about developing health and health patronage.
Loss of Phb2 in β-cells induces development of diabetes over a 3-week period in β-Phb2−/− mice. Loss of Phb2 in β-cells induces development of diabetes.
Comparison of the percentages of ducts in the pancreas containing cells showing positive staining for the different markers between control patients and.
Effects of vinegar (□) and placebo (⧫) on plasma glucose (A–C) and insulin (D–F) responses after a standard meal in control subjects, insulin-resistant.
Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: How Do They Exert Their Metabolic Actions? Part 7.
Case report: male 63 years old with documented stenosis of the internal cerebral artery, diabetes duration 12 years, and treatment with 22 IU insulin glargine.
Plasma glucose (A), serum insulin (B), serum C peptide (C) and plasma GLP-1 level (D) during the 2-hour OGTT among subjects with normal glucose tolerance.
Postprandial glucose, insulin and glucagon-like peptide-1 (GLP-1) levels following carbohydrate-first (CF), carbohydrate-last (CL) and sandwich (S) meal.
Pathophysiology and drug targets.
Outline of study protocol.
Hyperglycemic Targets & Hypoglycemia
Pharmacodynamic and pharmacokinetic evaluation of EXE-RM-LNC in a high-fat diet (HFD)-induced obese/diabetic mouse model following acute treatment. Pharmacodynamic.
Presentation transcript:

Conclusion Diabetes mellitus is actually one of the most popular chronic ailments in nearly whole countries

Diabetes is actually of two kinds

However, epidemiological information is essential not merely for health patronage frameworks

What's more, Kind 1 diabetes is depicted by selective lack of insulin-manufacturing β-cells

Recognition of genes inducing to kind one diabetes mellitus

Diabetes may be determined based on A1C standard or plasma glucose standard

However, the PAPM a phase-founded model that determines phases along the path

The initial insulin analogues utilized in insulin treatment were the fast-acting insulin analogues (lispro and aspart)

The initial extended-acting insulin parallel, insulin glargine

Consistent with the significance of gastric emptying and glucagon suppression for GLP-1 act

Anyway, at what time a behavior is plain and impedance is low, phase may concern little

In contrast, when alteration is harsh and impedance is elevated

The limiting pharmacodynamic and pharmacokinetic merits of standard insulins

Anyway, this interest has introduced insulin parallels

In fact, it would be unattainable to discover the function of a factor

Phase methods propose that we will be preferable able to recognize essential obstacles